- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
ViroPharma Inc+ Add to Watchlist
VPHM:US49.8600 USD 0.0900 0.18%
As of 14:28:34 ET on 12/20/2013.
Company Profile for ViroPharma Inc (VPHM)
ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.
Key Executives for ViroPharma Inc (VPHM)
|Vincent J Milano "Vin"Chairman/President/CEO||Charles A Rowland JrVP/CFO|
|Daniel B SolandVP/COO||Colin BroomVP/Chief Scientific Officer|
|Robert G PietruskoVP:Regulatory||J Peter WolfVP/Secretary/Gen Cnsl|